Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
79 hedge funds and large institutions have $47.6M invested in Ampio Pharmaceuticals Inc. in 2014 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 10 closing their positions.
146% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 13
50% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 10
5% more funds holding
Funds holding: 75 → 79 (+4)
59% less capital invested
Capital invested by funds: $116M → $47.6M (-$68.6M)
63% less call options, than puts
Call options by funds: $853K | Put options by funds: $2.32M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$2.28M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.49M |
| 3 |
Morgan Stanley
New York
|
+$1.07M |
| 4 |
IMS
Index Management Solutions
Philadelphia,
Pennsylvania
|
+$929K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$633K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$7.02M |
| 2 |
TC
Talkot Capital
Sausalito,
California
|
-$3.01M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.6M |
| 4 |
Millennium Management
New York
|
-$670K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$469K |
AMPE Hedge Fund Activity: Q3 2014 in Review
79 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2014, worth a combined $47.6M — down 59% from $116M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new AMPE positions and 10 closed out — a net gain of 5 holders — while 32 added to existing stakes and 13 trimmed.
The largest buyer was Knoll Capital Management, adding an estimated $2.28M. The largest seller was DAFNA Capital Management, cutting an estimated $7.02M.
- 79 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2014, up from 75 in Q2 2014.
- Funds reported $47.6M of Ampio Pharmaceuticals Inc. stock for Q3 2014, down 59% quarter-over-quarter.
- 15 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2014 and 10 closed out, a net change of +5 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q3 2014 was Knoll Capital Management, an estimated $2.28M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q3 2014 was DAFNA Capital Management, an estimated $7.02M sold.
Based on aggregated 13F filings for Q3 2014.